Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/AGY stock hub

AIM/AGY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/AGYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

687.1M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/AGY

In the news

Latest news · AIM/AGY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-163.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/AGY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

GBP

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	584
Employees Change	-18%
Employees Change Percent	-2.99
Enterprise value	GBX 703.7M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	GB00B02LCQ05
Last refreshed	2026-05-10
Market cap	GBX 687.1M
Price	GBX 10.85
Price currency	GBX
Rev Per Employee	98,106.16x
Sector	Healthcare
Sic	2836
Symbol	aim/AGY
Website	https://www.allergytherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.01%
EV Earnings	-14.61x
EV/FCF	-18.94x
EV/Sales	12.28x
FCF yield	-5.41%
P/B ratio	161.7x
P/S ratio	11.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-59.58%
EBITDA Margin	-55.16%
Gross margin	52.22%
Gross Profit	GBX 29.9M
Gross Profit Growth	2.11%
Gross Profit Growth Q	2.96%
Gross Profit Growth3 Y	0.2%
Gross Profit Growth5 Y	-2.09%
Net Income	GBX -48.2M
Net Income Growth Years	2%
Pretax Margin	-82.33%
Profit Margin	-84.08%
Profit Per Employee	GBX -82,491
ROA	-29.64
Roa5y	-19.42
ROCE	-87.58
ROIC	-163.2
Roic5y	-88.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.83%
Cagr15y	2.78%
Cagr1y	47.66%
Cagr20y	-7.47%
Cagr3y	55.64%
Cagr5y	1.76%
EPS Growth Years	2
Revenue Growth	2.94x
Revenue Growth Q	6.61x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	1.25x
Revenue Growth5 Y	-0.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.8
Assets	GBX 71M
Cash	GBX 10.1M
Current Assets	GBX 36.3M
Current Liabilities	GBX 32M
Debt	GBX 26.8M
Debt Equity	GBX 6.3
Debt FCF	GBX -0.72
Equity	GBX 4.2M
Interest Coverage	-4.88
Liabilities	GBX 66.8M
Long Term Assets	GBX 34.8M
Long Term Liabilities	GBX 34.7M
Net Cash	GBX -16.7M
Net Cash By Market Cap	GBX -2.43
Net Debt Equity	GBX 3.92
Tangible Book Value	GBX 49,000
Tangible Book Value Per Share	GBX 0
WACC	9.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.13
Inventory Turnover	2.13
Net Working Capital	GBX -3.9M
Quick ratio	0.7
Working Capital	GBX 4.2M
Working Capital Turnover	GBX 5.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-8.01%
1Y total return	47.62%
200-day SMA	9.85
3Y total return	277.14%
50-day SMA	10.84
50-day SMA vs 200-day SMA	50over200
5Y total return	9.13%
All Time High	146
All Time High Change	-92.57%
All Time High Date	2007-02-05
All Time Low	0.8
All Time Low Change	1,256.25%
All Time Low Date	2023-06-22
ATR	1.22
Beta	0.89
Beta1y	0.51
Beta2y	0.33
Ch YTD	-1.36
High	10.85
High52	12.1
High52 Date	2026-02-26
High52ch	-10.33%
Low	9.5
Low52	6.5
Low52 Date	2025-06-24
Low52ch	66.92%
Ma50ch	0.13%
Price vs 200-day SMA	10.16%
RSI	52.99
RSI Monthly	59.17
RSI Weekly	54.45
Sharpe ratio	0.95x
Sortino ratio	1.52
Total Return	-4.81%
Tr YTD	-1.36
Tr15y	50.86%
Tr1m	0.46%
Tr1w	5.85%
Tr3m	-0.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -34.1M
Operating margin	-59.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	724,989,155%
Net Borrowing	26,706,000
Shares Insiders	0.14%
Shares Institutions	4.22%
Shares Out	6,332,529,550
Shares Qo Q	9.62%
Shares Yo Y	4.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -39.1M
Average Volume	170,124.05x
Bv Per Share	0
CAPEX	GBX -4.6M
Ch10y	-57.66
Ch15y	-30.56
Ch1m	0.46
Ch1w	5.85
Ch1y	47.62
Ch20y	-90.25
Ch3m	-0.46
Ch3y	73.6
Ch5y	-49.77
Ch6m	27.65
Change	5.85%
Change From Open	14.21
Close	10.25
Days Gap	-7.32
Depreciation Amortization	2,531,000
Dollar Volume	1,287,200.6
Earnings Date	2026-06-29
EBIT	GBX -34.1M
EBITDA	GBX -31.6M
EPS	GBX -0.01
F Score	2
FCF	GBX -37.2M
FCF EV Yield	-5.28x
FCF Per Share	GBX -0.01
Financing CF	25,494,000
Fiscal Year End	June
Founded	1,998
Goodwill	3,340,000
Income Tax	GBX 1M
Investing CF	-4,224,000
Is Primary Listing	1
Last Earnings Date	2025-12-29
Last Report Date	2025-12-31
Ma150	10.36
Ma150ch	4.76%
Ma20	10.63
Ma20ch	2.12%
Net CF	-11,592,000
Next Earnings Date	2026-06-29
Open	9.5
Position In Range	100
Ppne	26,389,000
Price Date	2026-05-08
Ptbv Ratio	14,022
Relative Volume	0.71x
Revenue	57,294,000x
SBC By Revenue	3.42x
Share Based Comp	1,958,000
Tax By Revenue	1.76x
Tr20y	-78.81%
Tr6m	27.65%
Volume	118,636
Z Score	-2.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/AGY pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/AGY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/AGY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.2%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.8%

Negative means the company is buying back shares.

Technical

AIM/AGY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.0

Neutral momentum band

Price vs 200-day MA

+10.2%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/AGY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/AGY stock rating?

aim/AGY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/AGY analysis?

The full report lives at /stocks/aim/AGY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/AGY?

The latest report frames aim/AGY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/AGY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.